The Greater China country group, comprising the People's Republic of China, Hong Kong and Taiwan,
is Bayer's second largest market in Asia. The People's Republic of China plays an increasingly
important part in Bayer's investment plans. With China's manufacturing and construction industries
expanding rapidly, the country is becoming an increasingly important market for Bayer's polymer
products and a focus for capital expenditures. In the Shanghai Chemical Industry Park in the south
of Shanghai, Bayer is currently building new facilities for the production of polymer and raw
materials. With a planned investment of about US$ 1.8 billion, this is Bayer's biggest single
capital expenditure project worldwide, and it makes the company one of the major investors in the
People's Republic of China.